Streetbeat News

Stock Prices

CADL

Candel Therapeutics Inc (NASDAQ:CADL) released initial interim survival and immunological biomarker data from the ongoing phase 2 trial of CAN-2409 plus valacyclovir for pancreatic ductal adenocarcinoma (PDAC). The data showed a survival rate of 71.4% at both 24 and 36 months in patients who received the CAN-2409 regimen, versus only 16.7% in patients with standard of care chemoradiation. The company's shares are up 20.86% at $0.82.

Portfolio Pulse from Vandana Singh

November 06, 2023 | 6:04 pm

PLUS

ePlus (NASDAQ:PLUS) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $1.34. The company's past performance shows a trend of beating EPS estimates, which has led to increases in share price. The stock is currently trading at $65.01, up 30.41% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:02 pm

LEU

Centrus Energy (AMEX:LEU) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $0.23. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock was trading at $54.89 as of November 3, with a 19.92% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:02 pm

IOVA

Iovance Biotherapeutics (NASDAQ:IOVA) is set to release its quarterly earnings report on Tuesday, 2023-11-07. Analysts estimate an EPS of $-0.45. The company's past performance shows it beat EPS estimates last quarter, leading to a 6.44% increase in share price. However, the stock has been down 48.37% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:02 pm

XNCR

Xencor (NASDAQ:XNCR) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.73. The company's past performance shows a pattern of beating EPS estimates, which often leads to an increase in share price. However, the stock has been down 37.53% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:02 pm

GLDD

Great Lakes Dredge & Dock (NASDAQ:GLDD) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an EPS of $-0.11. The company's past performance shows a pattern of share price drops following earnings beats. The stock was trading at $7.55 as of November 3, with a 52-week increase of 11.04%.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:02 pm

MRSN

Mersana Therapeutics (NASDAQ:MRSN) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.36. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $1.42, down 78.69% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:01 pm

FSTR

L.B. Foster (NASDAQ:FSTR) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $0.25. The company's past performance shows a trend of beating EPS estimates, which has led to increases in share price. The stock is currently trading at $21.0 and has seen an 88.31% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:01 pm

ACEL

Accel Entertainment (NYSE:ACEL) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $0.17. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $10.38 and has seen a 10.45% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:01 pm

LQDA

Liquidia (NASDAQ:LQDA) is set to announce its latest quarterly earnings report on November 7, 2023. Analysts estimate an EPS of $-0.21. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. The stock is currently trading at $6.65, up 32.26% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 6:01 pm